Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

Document › Details

VectivBio Holding AG. (4/19/23). "Press Release: VectivBio Reports Full Year 2022 Financial Results and Provides Business Update". Basel.

	Organisation	VectivBio Holding AG (Nasdaq: VECT)
	Group	Ironwood (Group)
	Product	apraglutide
	Product 2	CoMET platform (modular, small molecule) (VectivBio)
	Person	Santarelli, Luca (VectivBio 202001– CEO before Therachon CEO + Roche 201110 Global Head Neuroscience Translational Area)

Original document
accessed by [iito] on 2023-04-26

Record changed: 2024-01-20

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for Ironwood (Group)

[1] Abivax S.A.. (8/23/23). "Press Release: Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations". Paris....
[2] VectivBio AG. (5/22/23). "Press Release: Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases". Boston, MA & Basel....
[3] VectivBio Holding AG. (3/13/23). "Press Release: VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan". Basel....
[4] VectivBio Holding AG. (4/21/22). "Press Release: VectivBio Appoints Patrick Malloy as Senior Vice President, Investor Relations & Strategic Communications". Basel....
[5] VectivBio Holding AG. (3/30/22). "Press Release: VectivBio Announces Japan License Deal and Loan Facility Agreement, Providing up to $117 Million to Fuel the Company Through Key Catalysts". Basel....
[6] Alentis Therapeutics AG. (11/9/21). "Press Release: Alentis Therapeutics Announces Board Appointments". Basel....
[7] VectivBio Holding AG. (9/21/21). "Press Release: VectivBio Announces Closing of Comet Therapeutics Acquisition". Basel....
[8] VectivBio Holding AG. (9/8/21). "Press Release: VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary". Basel....
[9] VectivBio Holding AG. (8/31/21). "Press Release: VectivBio to Acquire Comet Therapeutics and Host R&D Day". Basel....
[10] VectivBio Holding AG. (4/13/21). "Press Release: VectivBio Announces Closing of $146.6 Million Initial Public Offering". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]